Activatable photothermal agents with target-initiated large spectral separation for highly effective reduction of side effects
Sign Up to like & getrecommendations! Published in 2022 at "Chemical Science"
DOI: 10.1039/d2sc02467e
Abstract: Photothermal agents (PTAs) with minimized side effects are critical for transforming cancer photothermal therapy (PTT) into clinical applications. However, most currently available PTAs lack true selective activation to reduce side effects because of heavy spectral… read more here.
Keywords: spectral separation; photothermal agents; side; side effects ... See more keywords